ロード中...

High levels of serum glypican‐1 indicate poor prognosis in pancreatic ductal adenocarcinoma

Carbohydrate antigen 19‐9 (CA19‐9) fails to demonstrate the predictive value for early detection pancreatic ductal adenocarcinoma (PDAC). Glypican‐1 (GPC1+) exosomes may serve as a noninvasive diagnostic tool to detect early stages of PDAC. Therefore, it is necessary to explore the serum GPC1 levels...

詳細記述

保存先:
書誌詳細
出版年:Cancer Med
主要な著者: Zhou, Cong‐ya, Dong, Yi‐ping, Sun, Xiao, Sui, Xin, Zhu, Hong, Zhao, Ya‐qin, Zhang, Yuan‐yuan, Mason, Clifford, Zhu, Qing, Han, Su‐xia
フォーマット: Artigo
言語:Inglês
出版事項: John Wiley and Sons Inc. 2018
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6246926/
https://ncbi.nlm.nih.gov/pubmed/30358133
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1833
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!